Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control.
Saved in:
| Title: | Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control. |
|---|---|
| Authors: | Pyo KH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, South Korea., Rahman SMM; International Centre for Diarrhoeal Disease Research (iccdr,b), Dhaka, Bangladesh., Boraschi D; Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China.; Institute of Biochemistry and Cell Biology, National Research Council (CNR), Napoli, Italy.; Stazione Zoologica Anton Dohrn (SZN), Napoli, Italy.; China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation, Shenzhen, China. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Jan 10; Vol. 12, pp. 1121120. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2022). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2022.1121120 |
